FDA approves new labeling claims for Tecnis IOL


Pfizer Inc. announces that the FDA has approved new labeling claims forits Tecnis IOL. The approval marks the first time a lens has received suchclaims for reduction of postoperative spherical abberations and improvednight-driving simulator performance, the company said in a prepared statement.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.